WHO ICTRP trial
A clinical trial to study the effect of drug named Sofosbuvir in hospitalized…
CTRI/2020/06/025760 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/06/025760 |
|---|---|
| Public title | A clinical trial to study the effect of drug named Sofosbuvir in hospitalized patients with COVID 19. |
| Scientific title | Efficacy of Sofosbuvir in the management of hospitalized COVID 19 patients. |
| Primary sponsor | Dr N Babu |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere |
| Interventions | Intervention1: Drug sofosbuvir: sofosbuvir 400 mg twice daily for 10 days in all eligible study subjects along with standard of care including tablet hydroxy chloroquine 400 mg twice a day on day 1 followed by 200 mg twice a day upto day 5… |
| Registration date | Sep 6, 2020 |
| Target size | 50 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: